All terms in EFO
| Label | Id | Description |
|---|---|---|
| isovalerylcarnitine measurement | EFO_0020019 | [Quantification of isovalerylcarnitine levels in a sample.] |
| Spondyloepiphyseal dysplasia | HP_0002655 | [A disorder of bone growth affecting the vertebrae and the ends of the long bones (epiphyses).] |
| Skeletal dysplasia | HP_0002652 | [A general term describing features characterized by abnormal development of bones and connective tissues.] |
| diacylglycerol 33:3 measurement | EFO_0020057 | [The quantification of diacylglycerol 33:3 levels in a sample, typically blood ] |
| diacylglycerol 34:0 measurement | EFO_0020058 | [The quantification of diacylglycerol 34:0 levels in a sample, typically blood ] |
| diacylglycerol 34:3 measurement | EFO_0020059 | [The quantification of diacylglycerol 34:3 levels in a sample, typically blood ] |
| diacylglycerol 28:0 measurement | EFO_0020053 | [The quantification of diacylglycerol 28:0 levels in a sample, typically blood ] |
| diacylglycerol 32:0 measurement | EFO_0020054 | [The quantification of diacylglycerol 32:0 levels in a sample, typically blood ] |
| Bone pain | HP_0002653 | [An unpleasant sensation characterized by physical discomfort (such as pricking, throbbing, or aching) localized to bone.] |
| diacylglycerol 32.2 measurement | EFO_0020055 | [The quantification of diacylglycerol 32:2 levels in a sample, typically blood ] |
| Abnormal skeletal morphology | HP_0011842 | [An abnormality of the form, structure, or size of the skeletal system.] |
| diacylglycerol 33:1 measurement | EFO_0020056 | [The quantification of diacylglycerol 33:1 levels in a sample, typically blood ] |
| HUES45 | EFO_0007082 | [Human embryonic stem cell line derived from human blastocysts. [PMCID:PMC3335201]. Cells were provided by Harvard University and maintained on 10% KOSR (Invitrogen) medium.] |
| obsolete_atypical Norrie disease due to monosomy Xp11.3 | Orphanet_261501 | |
| bile acid measurement | EFO_0020050 | [The quantification of diacylglycerol 30:1 levels in a sample, typically blood ] |
| HUES44 | EFO_0007081 | [Human embryonic stem cell line derived from human blastocysts. [PMCID:PMC3335201]. Cells were provided by Harvard University and maintained on 10% KOSR (Invitrogen) medium.] |
| diacylglycerol 30:1 measurement | EFO_0020051 | [The quantification of diacylglycerol 30:0 levels in a sample, typically blood ] |
| HUES3 | EFO_0007080 | [Human embryonic stem cell line with a normal 46XY karyotype, pluripotency tested in vitro and in vivo. The stem cells were derived from human blastocysts and are strongly positive for a number of molecular markers of undifferentiated pluripotent human stem cells, including SSEA-3, SSEA-4, TRA-1-60, TRA-1-81, and alkaline phosphatase. [DOI: 10.1056/NEJMsr040330]. Cells were provided by Harvard University and maintained on KSR medium.] |
| diacylglycerol 30:0 measurement | EFO_0020052 | [The quantification of diacylglycerol 30:1 levels in a sample, typically blood ] |
| HUES6 | EFO_0007086 | [Human embryonic stem cell line with a normal 46XX karyotype, pluripotency tested in vitro and in vivo. The stem cells were derived from human blastocysts and are strongly positive for a number of molecular markers of undifferentiated pluripotent human stem cells, including SSEA-3, SSEA-4, TRA-1-60, TRA-1-81, and alkaline phosphatase. [DOI: 10.1056/NEJMsr040330]. Cells were provided by Harvard University and maintained on KSR medium.] |